mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.002 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.41 |
0.002 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.003 |